VRS
IBRX icon

Virginia Retirement Systems’s ImmunityBio IBRX Stock Holding History

Virginia Retirement Systems’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,000
Closed -$55.8K – 1136
2022
Q4 		$55.8K Sell
11,000
-3,100
-22% -$17K ﹤0.01% 1111
2022
Q3 		$70.1K Buy
+14,100
New +$64.3K ﹤0.01% 1130
2022
Q1 		$122K Buy
21,800
+8,300
+61% +$50.9K ﹤0.01% 1083
2021
Q4 		$82 Buy
+13,500
New +$101K ﹤0.01% 1091

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Virginia Retirement Systems's IBRX Position: Q1 2023 in Review

Virginia Retirement Systems sold out of ImmunityBio (IBRX) in Q1 2023, closing a stake of 11,000 shares — an estimated $55.8K sold.

Virginia Retirement Systems first reported a position in IBRX in Q4 2021 and held it in 4 quarters. The position peaked at $122K in Q1 2022. 146 funds tracked by Wall St. Rank hold IBRX as of Q1 2023.

  • Virginia Retirement Systems reported no remaining ImmunityBio position as of Q1 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 11,000 ImmunityBio shares in Q1 2023, an estimated $55.8K.
  • Virginia Retirement Systems first reported a position in ImmunityBio in Q4 2021 and held it in 4 quarters.
  • Virginia Retirement Systems's ImmunityBio position peaked at $122K in Q1 2022.
  • 146 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2023.

Based on Virginia Retirement Systems's 13F filing for Q1 2023, filed 11 Jul 2023.